Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey P Callen

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Dermatologic Clinics|April 14, 2007
Newly recognized cutaneous drug eruptionsJeffrey P Callen
Clinics in Dermatology|July 27, 2018
Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 yearsJeffrey P Callen
Current Rheumatology Reports|April 29, 2010
Cutaneous manifestations of dermatomyositis and their managementJeffrey P Callen
Archives of Dermatology|March 18, 2009
Clinically relevant information about cutaneous lupus erythematosusJeffrey P Callen
Current Allergy and Asthma Reports|July 9, 2008
Immunomodulatory treatment for dermatomyositisJeffrey P Callen
Journal of the American Academy of Dermatology|September 1, 2004
Collagen vascular diseasesJeffrey P Callen
The Medical Clinics of North America|June 1, 2021
Skin Signs of Systemic DiseasesJeffrey P Callen
The American Journal of the Medical Sciences|July 31, 2017
Hepatitis C Viral Infection and Porphyria Cutanea TardaJeffrey P Callen
Best Practice & Research. Clinical Rheumatology|September 10, 2005
Management of "refractory" skin disease in patients with lupus erythematosusJeffrey P Callen
Journal of the American Academy of Dermatology|August 2, 2003
New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: a personal appraisal of their use in practiceJeffrey P Callen
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Dermatologic Clinics|April 14, 2007
Newly recognized cutaneous drug eruptionsJeffrey P Callen
Clinics in Dermatology|July 27, 2018
Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 yearsJeffrey P Callen
Current Rheumatology Reports|April 29, 2010
Cutaneous manifestations of dermatomyositis and their managementJeffrey P Callen
Archives of Dermatology|March 18, 2009
Clinically relevant information about cutaneous lupus erythematosusJeffrey P Callen
Current Allergy and Asthma Reports|July 9, 2008
Immunomodulatory treatment for dermatomyositisJeffrey P Callen
Journal of the American Academy of Dermatology|September 1, 2004
Collagen vascular diseasesJeffrey P Callen
The Medical Clinics of North America|June 1, 2021
Skin Signs of Systemic DiseasesJeffrey P Callen
The American Journal of the Medical Sciences|July 31, 2017
Hepatitis C Viral Infection and Porphyria Cutanea TardaJeffrey P Callen
Best Practice & Research. Clinical Rheumatology|September 10, 2005
Management of "refractory" skin disease in patients with lupus erythematosusJeffrey P Callen
Journal of the American Academy of Dermatology|August 2, 2003
New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: a personal appraisal of their use in practiceJeffrey P Callen
Pageof 17